What you'll discover in this report
The New Reality of Pharmaceutical Supply Chains
Geopolitical tensions, labor shortages, and pandemic aftershocks have exposed critical vulnerabilities in traditional manufacturing models. Industry leaders are prioritizing resilience and regionalization over cost optimization alone. Discover what this strategic pivot means for your organization and how to balance supply chain security with surging demand across the continent.
Reshoring: Promise and Practicality
American pharmaceutical manufacturing is experiencing a renaissance. Explore the collaborative production models, strategic partnerships, and infrastructure investments bringing critical capabilities back home—plus the startup bottlenecks, infrastructure requirements, and workforce challenges that still need solving.
The Technology Imperative
AI, digital twins, advanced analytics, and cybersecurity innovations are no longer optional—they're operational imperatives. Learn how forward-thinking companies are deploying these technologies to achieve real-time visibility, predictive maintenance, quality assurance at scale, and the operational agility required to anticipate disruptions before they cascade through the system.
Miami: The Emerging Pharmaceutical Hub of the Americas
South Florida has emerged as an increasingly important center for healthcare innovation, attracting healthcare investors, medtech organizations, biotechnology companies and international healthcare stakeholders. The region's growing influence aligns closely with CPHI Americas' mission of connecting industry leaders, advancing innovation and facilitating strategic partnerships across the pharmaceutical value chain.
Miami's appeal among private equity firms, venture capital groups, healthcare investors and international business organizations creates an environment that extends beyond traditional conference networking.
This environment is expected to support increased participation from pharmaceutical executives, investors and senior decision-makers, further strengthening the quality of conversations and partnerships formed at the event.
Report insights gathered from CPHI Americas, Philadelphia | Featuring perspectives from 3,000+ attendees representing leading organizations including Pfizer, Takeda, Bayer, and 80+ expert speakers across five dedicated content tracks
